The Supreme Court and DNA Patents: A Myriad of Ramifications
Monday, July 1, 2013
Wilson Sonsini Goodrich & Rosati
650 Page Mill Road
Palo Alto, CA 94304
Panel Discussion 3:30-5:30 PM
Networking Reception 5:30-7:00 PM
In Association for Molecular Pathology v Myriad Genetics,
Inc., a unanimous Supreme Court held that isolated
naturally-occurring human DNA is not patentable subject matter, but
synthetic c-DNA is patent eligible. On July 1, The Berkeley Center for
Law & Technology (BCLT) and the law firm of Wilson Sonsini
Goodrich and Rosati will co-host a panel on the meaning and impact of
the Court’s decision.
Panelists include:
Benjamin Jackson, Senior Director of Legal Affairs at Myriad Genetics
Nathan Kelley, Deputy Solicitor at US Patent and Trademark Office
Vern Norviel, Wilson Sonsini Goodrich & Rosati
Michael Shuster, Fenwick & West LLP
Judge Alex Kozinski, United States Court of Appeals for the Ninth Circuit
The panel will be held at Wilson Sonsini Goodrich &
Rosati’s Palo Alto office at 3:30 PM and will be followed by a
networking reception. Final logistics, including the exact location,
will be sent before the event.
attend, but pre-registration is
required.
Please contact Associate Director Louise Lee at llee@law.berkeley.edu to register.
2.0 hours of CLE credit will be available for this panel.